AGILENT TECHNOLOGIES, INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
AGILENT TECHNOLOGIES, INC. (A) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-09-01
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-07-31 was $0.00.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-04-30 was $0.00, a 100.00% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2026-01-31 was $0.00.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-10-31 was $0.00, a 100.00% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $15.00M, a 36.36% increase from fiscal 2024.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $11.00M.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $0.00.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2020 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2026-07-31 | $0.00 10-Q · filed 2026-09-01 | $0.00 derived: sum of 2 quarters · filed 2026-09-01 | $0.00 10-Q · filed 2026-09-01 | $0.00 derived: sum of 4 quarters · filed 2026-09-01 |
| 2026-04-30 | $0.00 10-Q · filed 2026-06-01 | $0.00 10-Q · filed 2026-06-01 | $0.00 derived: sum of 3 quarters · filed 2026-06-01 | $0.00 derived: sum of 4 quarters · filed 2026-09-01 |
| 2026-01-31 | $0.00 10-Q · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 derived: sum of 3 quarters · filed 2026-09-01 | $15.00M derived: sum of 4 quarters · filed 2026-09-01 |
| 2025-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-22 | $0.00 derived: sum of 2 quarters · filed 2026-09-01 | $15.00M derived: sum of 3 quarters · filed 2026-09-01 | $15.00M 10-K · filed 2025-12-22 |
| 2025-07-31 | $0.00 10-Q · filed 2026-09-01 | $15.00M derived: sum of 2 quarters · filed 2026-09-01 | $15.00M 10-Q · filed 2026-09-01 | $26.00M derived: sum of 4 quarters · filed 2026-09-01 |
| 2025-04-30 | $15.00M 10-Q · filed 2026-06-01 | $15.00M 10-Q · filed 2026-06-01 | $26.00M derived: sum of 3 quarters · filed 2026-06-01 | $26.00M derived: sum of 4 quarters · filed 2026-06-01 |
| 2025-01-31 | $0.00 10-Q · filed 2026-03-03 | $11.00M derived: sum of 2 quarters · filed 2026-03-03 | $11.00M derived: sum of 3 quarters · filed 2026-03-03 | $11.00M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-10-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-22 | $11.00M derived: sum of 2 quarters · filed 2025-12-22 | $11.00M derived: sum of 3 quarters · filed 2025-12-22 | $11.00M 10-K · filed 2025-12-22 |
| 2024-07-31 | $0.00 10-Q · filed 2025-08-29 | $0.00 derived: sum of 2 quarters · filed 2025-08-29 | $0.00 10-Q · filed 2025-08-29 | $0.00 derived: sum of 4 quarters · filed 2025-12-22 |
| 2024-04-30 | $0.00 10-Q · filed 2025-06-02 | $0.00 10-Q · filed 2025-06-02 | $0.00 derived: sum of 3 quarters · filed 2025-12-22 | $0.00 derived: sum of 4 quarters · filed 2025-12-22 |
| 2024-01-31 | $0.00 10-Q · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-12-22 | $0.00 derived: sum of 3 quarters · filed 2025-12-22 | $0.00 derived: sum of 4 quarters · filed 2025-12-22 |
| 2023-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-22 | $0.00 derived: sum of 2 quarters · filed 2025-12-22 | $0.00 derived: sum of 3 quarters · filed 2025-12-22 | $0.00 10-K · filed 2025-12-22 |
| 2023-07-31 | $0.00 10-Q · filed 2024-08-30 | $0.00 derived: sum of 2 quarters · filed 2024-08-30 | $0.00 10-Q · filed 2024-08-30 | $0.00 derived: sum of 4 quarters · filed 2024-09-03 |
| 2023-04-30 | $0.00 10-Q · filed 2024-06-03 | $0.00 10-Q · filed 2024-06-03 | $0.00 derived: sum of 3 quarters · filed 2024-09-03 | $0.00 derived: sum of 4 quarters · filed 2024-09-03 |
| 2023-01-31 | $0.00 10-Q · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-09-03 | $0.00 derived: sum of 3 quarters · filed 2024-09-03 | $0.00 derived: sum of 4 quarters · filed 2024-09-03 |
| 2022-10-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2024-09-03 | $0.00 derived: sum of 2 quarters · filed 2024-09-03 | $0.00 derived: sum of 3 quarters · filed 2024-09-03 | $0.00 8-K · filed 2024-09-03 |
| 2022-07-31 | $0.00 10-Q · filed 2023-08-31 | $0.00 derived: sum of 2 quarters · filed 2023-08-31 | $0.00 10-Q · filed 2023-08-31 | |
| 2022-04-30 | $0.00 10-Q · filed 2023-05-26 | $0.00 10-Q · filed 2023-05-26 | ||
| 2022-01-31 | $0.00 10-Q · filed 2023-03-03 | |||
| 2021-10-31 | $0.00 8-K · filed 2024-09-03 | |||
| 2020-10-31 | $0.00 10-K · filed 2022-12-21 | |||
| 2019-10-31 | $0.00 10-K · filed 2020-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |